Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Yun Shao

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Anticancer Research|October 2, 2019
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint InhibitorsJhe-Cyuan Guo, Chia-Chi Lin, Chen-Yuan Lin, et al.
Japanese Journal of Clinical Oncology|September 20, 2015
Young patients with colorectal cancer have increased risk of second primary cancersYi-Hsin Liang, Yu-Yun Shao, Ho-Min Chen, et al.
Journal of Cancer|July 30, 2016
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily PracticeYi-Hsin Liang, Yu-Yun Shao, Bin-Chi Liao, et al.
The Oncologist|April 3, 2012
The impact of diabetes mellitus on prognosis of early breast cancer in AsiaWei-Wu Chen, Yu-Yun Shao, Wen-Yi Shau, et al.
Cancer|December 6, 2012
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinomaLi-Chun Lu, Yu-Yun Shao, Raymond N C Kuo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 30, 2013
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapyYu-Yun Shao, Po-Chin Liang, Yao-Ming Wu, et al.
Oncology|February 8, 2012
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinomaYu-Yun Shao, Zhong-Zhe Lin, Chiun Hsu, et al.
BMC Cancer|March 1, 2022
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinomaYu-Yun Shao, Hung-Yang Kuo, Yung-Ming Jeng, et al.
British Journal of Cancer|March 25, 2025
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trialYu-Yun Shao, Ching-Tso Chen, Chien-Huai Chuang, et al.
Acta Cardiologica Sinica|March 13, 2023
Cancer-Associated Thrombosis: A Taiwanese Perspective on Therapeutic Options with Focus on Non-Vitamin K Antagonist Oral AnticoagulantsYu-Yun Shao, Ching-Liang Ho, Cheng-Shyong Chang, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Anticancer Research|October 2, 2019
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint InhibitorsJhe-Cyuan Guo, Chia-Chi Lin, Chen-Yuan Lin, et al.
Japanese Journal of Clinical Oncology|September 20, 2015
Young patients with colorectal cancer have increased risk of second primary cancersYi-Hsin Liang, Yu-Yun Shao, Ho-Min Chen, et al.
Journal of Cancer|July 30, 2016
Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily PracticeYi-Hsin Liang, Yu-Yun Shao, Bin-Chi Liao, et al.
The Oncologist|April 3, 2012
The impact of diabetes mellitus on prognosis of early breast cancer in AsiaWei-Wu Chen, Yu-Yun Shao, Wen-Yi Shau, et al.
Cancer|December 6, 2012
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinomaLi-Chun Lu, Yu-Yun Shao, Raymond N C Kuo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 30, 2013
A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced hepatocellular carcinoma who have failed anti-angiogenic therapyYu-Yun Shao, Po-Chin Liang, Yao-Ming Wu, et al.
Oncology|February 8, 2012
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinomaYu-Yun Shao, Zhong-Zhe Lin, Chiun Hsu, et al.
BMC Cancer|March 1, 2022
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinomaYu-Yun Shao, Hung-Yang Kuo, Yung-Ming Jeng, et al.
British Journal of Cancer|March 25, 2025
Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trialYu-Yun Shao, Ching-Tso Chen, Chien-Huai Chuang, et al.
Acta Cardiologica Sinica|March 13, 2023
Cancer-Associated Thrombosis: A Taiwanese Perspective on Therapeutic Options with Focus on Non-Vitamin K Antagonist Oral AnticoagulantsYu-Yun Shao, Ching-Liang Ho, Cheng-Shyong Chang, et al.
Pageof 12